Coronavirus vaccine: Engineered virus tested on mice offers hope for protection against Covid-19, scientists say
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.A new study on mice offers hope for a vaccine against coronavirus, according to the researchers behind it.
The latest research successfully protected mice against a lethal dose of Mers, a very close relative of the new coronavirus that causes Covid-19.
Scientists suggest that the same delivery method could work against Sars-CoV-2, the virus responsible for ongoing Covid-19 pandemic.
In the research, scientists used another virus that is harmless in humans, engineered so that it would produce the glycoprotein known to be involved in Mers infections. Mice inhaled the virus in one single dose.
When those same mice were exposed to a usually lethal dose of Mers, four weeks later, all of them survived.
Scientists now hope they can use the largely harmless virus – known as parainfluenza virus 5 or PIV5 – to deliver vaccines for other coronavirus diseases.
“Our new study indicates that PIV5 may be a useful vaccine platform for emerging coronavirus diseases, including Sars-CoV-2, the virus causing the ongoing Covid-19 pandemic,” said Paul McCray, a professor at the UI Carver College of Medicine and one of the authors of the study.
“Using the same strategy, vaccine candidates based on PIV5 expressing the spike protein of Sars-CoV-2 have been generated. We are planning more studies in animals to test the ability of PIV5-based vaccines in preventing disease caused by Sars-CoV-2.”
The research is published this week in mBio, a journal of the American Society of Microbiology.
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments